The longer-term cognitive effects of adjunctive antiepileptic treatment with lacosamide in comparison with lamotrigine and topiramate in a naturalistic outpatient setting

Epilepsy and Behavior

Volumn 26, Issue 2, 2013, Pages 182-187

  Helmstaedter, Christoph ^a   Witt, Juri Alexander ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

Antiepileptic drugs; Cognition; Epilepsy; Executive functions; Memory; Neuropsychological assessment; Quality of life

Indexed keywords

HARKOSERIDE; LAMOTRIGINE; TOPIRAMATE;

ADJUVANT THERAPY; ADULT; ALERTNESS; ANXIETY; ARTICLE; ATTENTION; COGNITION; CONTROLLED STUDY; DEPRESSION; DIZZINESS; EPILEPSY; EXECUTIVE FUNCTION; FEMALE; FLUENCY DISORDER; FOLLOW UP; HUMAN; IRRITABILITY; LEARNING; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MOOD; NAUSEA; OUTCOME ASSESSMENT; OUTPATIENT CARE; PSYCHOMOTOR ACTIVITY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETROSPECTIVE STUDY; SELF REPORT; SPATIAL MEMORY; UNSPECIFIED SIDE EFFECT; VERBAL MEMORY; WEIGHT GAIN; WEIGHT REDUCTION;

ACETAMIDES; ADOLESCENT; ADULT; ANTICONVULSANTS; COGNITION; EPILEPSY; EXECUTIVE FUNCTION; FEMALE; FRUCTOSE; HUMANS; MALE; MEMORY; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; OUTPATIENTS; QUALITY OF LIFE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; TRIAZINES;

EID: 84872598941     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2012.11.052     Document Type: Article

References (25)

1. Bootsma H.P., Ricker L., Hekster Y.A., et al. The impact of side effects on long-term retention in three new antiepileptic drugs. Seizure 2009, 18:327-331.
2. Ben-Menachem E., Biton V., Jatuzis D., Abou-Khalil B., Doty P., Rudd G.D. Efficacy and safety of oral lacosamide as adjunctive therapy in adults with partial-onset seizures. Epilepsia 2007, 48:1308-1317.
3. Chung S., Sperling M.R., Biton V., et al. Lacosamide as adjunctive therapy for partial-onset seizures: a randomized controlled trial. Epilepsia 2010, 51:958-967.
4. Halasz P., Kalviainen R., Mazurkiewicz-Beldzinska M., et al. Adjunctive lacosamide for partial-onset seizures: efficacy and safety results from a randomized controlled trial. Epilepsia 2009, 50:443-453.
5. Hebert D., Helmstaedter C., Kanner A.M., Isojarvi J., Eggert A., Doty P. Preliminary evaluation of the risk of cognitive adverse events in lacosamide clinical trials for adjunctive treatment of partial onset seizures. Epilepsia 2009, 50:260-261.
6. Zaccara G., Perucca P., Loiacono G., Giovannelli F., Verrotti A. The adverse event profile of lacosamide: a systematic review and meta-analysis of randomized controlled trials. Epilepsia Jul. 10 2012, http://dx.doi.org/10.1111/j.1528-1167.2012.03589.x [Electronic publication ahead of print].
7. Lee S.A., Lee H.W., Heo K., et al. Cognitive and behavioral effects of lamotrigine and carbamazepine monotherapy in patients with newly diagnosed or untreated partial epilepsy. Seizure 2011, 20:49-54.
8. Meador K.J., Baker G.A. Behavioral and cognitive effects of lamotrigine. J Child Neurol 1997, 12(Suppl. 1):S44-S47.
9. Kockelmann E., Elger C.E., Helmstaedter C. Significant improvement in frontal lobe associated neuropsychological functions after withdrawal of topiramate in epilepsy patients. Epilepsy Res 2003, 54:171-178.
10. Lee H.W., Jung D.K., Suh C.K., Kwon S.H., Park S.P. Cognitive effects of low-dose topiramate monotherapy in epilepsy patients: a 1-year follow-up. Epilepsy Behav 2006, 8:736-741.
11. Witt JA, Elger CE, Helmstaedter C. Impaired verbal fluency under topiramate - evidence for synergistic negative effects of epilepsy, topiramate, and polytherapy. Eur J Neurol, in press, [Electronic publication ahead of print]. http://dx.doi.org/10.1111/j.1468-1331.2012.03814.x.
12. Blum D., Meador K., Biton V., et al. Cognitive effects of lamotrigine compared with topiramate in patients with epilepsy. Neurology 2006, 67:400-406.
13. Kockelmann E., Elger C.E., Helmstaedter C. Cognitive profile of topiramate as compared with lamotrigine in epilepsy patients on antiepileptic drug polytherapy: relationships to blood serum levels and comedication. Epilepsy Behav 2004, 5:716-721.
14. Meador K.J., Loring D.W., Vahle V.J., et al. Cognitive and behavioral effects of lamotrigine and topiramate in healthy volunteers. Neurology 2005, 64:2108-2114.
15. Chung S.S., Kerls S., Hammer A., Kustra R. Cognitive effects of lamotrigine versus topiramate as adjunctive therapy in older adults with epilepsy. Neurol Int 2009, 1:e6.
16. Gotte D. Consequences of the German AMNOG for the identification of study objectives to demonstrate clinical efficacy and cost effectiveness of innovative drugs. Dtsch Med Wochenschr 2012, 137:274-280.
17. EpiTrack Helmstaedter C. Veränderungssensitives kognitives Skreening zur Qualitäts- und Outcomekontrolle der medikamentösen Epilepsiebehandlung 2012, UCB-Pharma, Monheim. 2te Auflage.
18. Helmstaedter C., Witt J.A. The effects of levetiracetam on cognition: a non-interventional surveillance study. Epilepsy Behav 2008, 13:642-649.
19. Helmstaedter C., Witt J.A. Cognitive outcome of antiepileptic treatment with levetiracetam versus carbamazepine monotherapy: a non-interventional surveillance trial. Epilepsy Behav 2010, 18:74-80.
20. Witt J.A., Helmstaedter C. The impact of antiepileptic drug treatment on attention and executive functions. Epilepsia 2010, 51:20.
21. Helmstaedter C., Lendt M., Lux S. VLMT Verbaler Lern- und Merkfähigkeitstest 2001, Beltz Test GmbH, Göttingen.
22. Witt J.A., Helmstaedter C. Neuropsychology in epilepsy - part II: towards an establishment of diagnostic guidelines. Fortschr Neurol Psychiatr 2009, 77:691-698.
23. Cramer J.A., Perrine K., Devinsky O., Meador K. A brief questionnaire to screen for quality of life in epilepsy: the QOLIE-10. Epilepsia 1996, 37:577-582.
24. Verrotti A., Scaparrotta A., Agostinelli S., Di Pillo S., Chiarelli F., Grosso S. Topiramate-induced weight loss: a review. Epilepsy Res 2011, 95:189-199.
25. Witt J.A., Helmstaedter C. Monitoring the cognitive effects of antiepileptic pharmacotherapy - approaching the individual patient. Epilepsy Behav 2012, http://dx.doi.org/10.1016/j.yebeh.2012.09.015 [Electronic publication ahead of print].